Aarti Pharmalabs Limited (AARTIPHARM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE0LRU01027
Key metrics
- Market Cap
- ₹7,587 Cr
- P/E Ratio
- 37.12
- EPS
- 22.54
- Book Value
- 234.35
- P/B Ratio
- 3.58
- ROE
- 8.22%
- ROCE
- 10.35%
- Debt / Equity
- 0.36
- Net Margin
- 9.6%
- Revenue Growth
- -13.98%
- Profit Growth
- -35.86%
- Dividend Yield
- 0.48%
- 52W High
- ₹946.10
- 52W Low
- ₹585.00
- Market Cap Band
- mid cap
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Aarti Pharmalabs Limited
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 44.1%
The full Aarti Pharmalabs Limited analysis
Create a free account to open the complete AARTIPHARM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.